EFFECT OF PH ON THE STABILITY OF HEPARIN IN 5-PERCENT DEXTROSE SOLUTIONS

被引:8
作者
JOY, RT
HYNECK, ML
BERARDI, RR
HO, NFH
机构
[1] UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN HOSP,ANN ARBOR,MI 48109
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1979年 / 36卷 / 05期
关键词
D O I
10.1093/ajhp/36.5.618
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:618 / 621
页数:4
相关论文
共 23 条
[1]   DEXTROSE AND SORBITOL AS DILUENTS FOR CONTINUOUS INTRAVENOUS HEPARIN INFUSION [J].
CHESSELLS, JM ;
CHAMBERLAIN, DA ;
BRAITHWAITE, TA .
BMJ-BRITISH MEDICAL JOURNAL, 1972, 2 (5805) :81-+
[2]  
COON WW, 1978, CLIN PHARMACOL THER, V23, P139
[3]   CURRENT CONCEPTS - USE OF HEPARIN [J].
DEYKIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (17) :937-&
[4]   CHEMISTRY AND PHARMACOLOGY OF HEPARIN [J].
EHRLICH, J ;
STIVALA, SS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (04) :517-544
[5]   KINETICS OF HEPARIN [J].
ESTES, JW .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :187-&
[6]   KINETICS OF ANTICOAGULANT EFFECT OF HEPARIN [J].
ESTES, JW .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 212 (09) :1492-&
[7]   ANTITHROMBOTIC DRUGS .1. [J].
GALLUS, AS ;
HIRSH, J .
DRUGS, 1976, 12 (01) :41-68
[8]   GUIDELINES FOR HEPARIN THERAPY [J].
GENTON, E .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (01) :77-82
[9]  
HADGRAFT JW, 1970, LANCET, V2, P1254
[10]  
HODBY ED, 1972, CAN MED ASSOC J, V106, P562